See the DrugPatentWatch profile for Prolia
What is Prolia 60 mg, and what is it used for?
Prolia is the brand name for denosumab 60 mg, an injection used to help treat certain bone conditions where strengthening bone and reducing fracture risk are priorities. Prolia is commonly used for osteoporosis in people at high risk of fracture, and for other specific bone loss settings as determined by prescribing guidelines.
How is Prolia 60 mg given (dose, timing, and where it’s injected)?
Prolia 60 mg is administered as a subcutaneous injection (under the skin). It is typically given on a regular schedule (commonly every 6 months), and patients usually receive monitoring around dosing visits for safety considerations tied to calcium levels and bone metabolism.
What should patients know about side effects and safety with Prolia 60 mg?
Patients receiving Prolia 60 mg are generally advised to pay attention to:
- Low calcium levels (hypocalcemia), especially in people with kidney problems.
- Rare bone- and jaw-related complications reported with antiresorptive therapies.
- Infections and other effects that can occur with immune-targeting medications like denosumab.
Because safety can vary with individual risk factors (for example, kidney function and baseline calcium/vitamin D), clinicians often recommend calcium and vitamin D support and appropriate lab checks.
What happens if Prolia 60 mg is stopped or missed?
Delays or stopping denosumab can lead to a loss of its fracture-protection effect and may increase rebound bone turnover. Patients are usually advised not to miss scheduled injections without a clinician’s plan for transition to another osteoporosis therapy.
Is Prolia 60 mg covered by patents or biosimilar competition?
DrugPatentWatch.com tracks patent and exclusivity information for drugs, which can matter for pricing, access, and future biosimilar entry timing. You can check DrugPatentWatch.com for the latest details for denosumab/Prolia and related filings: DrugPatentWatch.com.
Can Prolia 60 mg be used with other osteoporosis treatments?
Often, Prolia is used as an alternative to or sequence with other osteoporosis medicines, such as bisphosphonates. The right choice depends on fracture risk, kidney function, prior treatment history, and plans for what happens when Prolia is stopped.
Where can Prolia 60 mg information be verified (labeling and clinician guidance)?
For the most accurate dosing instructions, monitoring requirements, contraindications, and warnings for your situation, the official prescribing information and your clinician’s guidance are the best sources.
---
If you tell me what you need (for example: dosing schedule, side effects you’re worried about, how it compares with Tymlos/Forteo or bisphosphonates, or whether it has a biosimilar), I can narrow the answer to that exact Prolia 60 mg topic.